Product Information
NICARDIPINE 20 MG CAPSULE is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $1.1201 per EA under NDC 62559020590. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Oct 28, 1996. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
62559020590
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NICARDIPINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074670FDA Approved
10/28/1996
TE Code
AB
On Market Since
6/25/2021
Pharmacological Classes
Price Statistics
The NADAC for NICARDIPINE 20 MG CAPSULE has been published 129 times since Apr 17, 2024, and over the history we have for it it has declined 58.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1201 per EA |
|---|---|
| All-time high | $3.3799 (Dec 11, 2024) |
| All-time low | $1.1201 (Sep 23, 2026) |
| 52-week high | $1.3727 |
| 52-week low | $1.1201 |
| Median price | $1.9979 |
| Average price | $1.9804 |
| Largest weekly change | -41.0% (Sep 17, 2025) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ANI Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nicardipine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Dihydropyridine Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NICARDIPINE 20 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for NICARDIPINE 20 MG CAPSULE, manufactured by ANI Pharmaceuticals, Inc., is $1.1201 per EA (NDC 62559020590), effective Sep 30, 2026.
How has the price of NICARDIPINE 20 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for NICARDIPINE 20 MG CAPSULE has declined 58.8%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for NICARDIPINE 20 MG CAPSULE?
Since Apr 17, 2024, the NADAC for NICARDIPINE 20 MG CAPSULE has ranged from a low of $1.1201 (Sep 23, 2026) to a high of $3.3799 (Dec 11, 2024), with a median of $1.9979 per EA.
Are there cheaper alternatives to NICARDIPINE 20 MG CAPSULE?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as NICARDIPINE 20 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures NICARDIPINE 20 MG CAPSULE?
NICARDIPINE 20 MG CAPSULE (NDC 62559020590) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.